|
Consolidation with Alemtuzumab in Patients with Chronic Lymphocytic Leukemia (CLL) in First Remission - Experience on Safety and Efficacy within a Randomized Multicenter Phase III Trial of the German CLL Study Group (GCLLSG). Session Type: Poster Session (click for details) |
|
|
|
A Multi-Center Evaluation of Bio-Rad Platelia Aspergillus GM EIA: Data Supporting FDA Approval of the Test Using a Low Cut-Off To Define Positivity. Session Type: Poster Session 833-III
(click for details) |
|
|
|
Hematopoietic Stem Cell Transplantation in Congenital Neutropenias: Recommendation for Patients Refractory to G-CSF Treatment and Secondary MDS or Leukemias. Session Type: Poster Session 83-I
(click for details) |
|
|
|
Effective Antifungal Prophylaxis with Fluconazole and Itraconazole in Patients Undergoing Hematopoetic Stem Cell Transplantation (HSCT): Single Centre Experience. Session Type: Publication Only (click for details) |
|
|
|
Effect of the Addition of Low-Dose Alemtuzumab (Campath) in Non-Myeloablative Unrelated Hematopoietic Transplantation in Patients with Lymphoid Malignancies. Session Type: Poster Session 875-I
(click for details) |
|
|
|
A Nationwide Survey on Deep Fungal Infections and Antifungal Prophylaxis for Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT): Revisit of the Guidelines from the Centers for Disease Control and Prevention (CDC). Session Type: Publication (click for details) |
|
|
|
Infectious Complications Following Allogeneic HLA-Identical Sibling Transplantation (allo-SCT) with Antithymocyte Globulin-Based Reduced Intensity Conditioning Regimen (RIC). Session Type: Poster Session 789-II
(click for details) |
|
|
|
A Pre-Induction Course with AraC and VP16 and with MTX for High Risk Improves Treatment Outcome in Adult Acute Lymphoblastic Leukemia (ALL). Session Type: Poster Session 501-III
(click for details) |
|
|
|
Safety of Voriconazole after Autologous and Allogeneic Stem Cell Transplantation. Session Type: Publication Only
(click for details) |
|
|
|
Successful Management of Invasive Pulmonary Aspergillosis (IPA) in Two Patients with High Risk Acute Leukemia by Combined Antifungal Treatment and Reduced Intensity Conditioning (RIC) Stem Cell Transplantation (SCT). Session Type: Publication Only
(click for details) |
|
|
